These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 15962414)

  • 1. Gene profiling coming of age in cancer therapy.
    Johns Hopkins Med Lett Health After 50; 2005 Jun; 17(4):4-6. PubMed ID: 15962414
    [No Abstract]   [Full Text] [Related]  

  • 2. Gene expression profiles of primary breast carcinomas from patients at high risk for local recurrence after breast-conserving therapy.
    Kreike B; Halfwerk H; Kristel P; Glas A; Peterse H; Bartelink H; van de Vijver MJ
    Clin Cancer Res; 2006 Oct; 12(19):5705-12. PubMed ID: 17020974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene-expression-based predictors for breast cancer.
    Goetz MP; Ingle JN; Couch FJ
    N Engl J Med; 2007 Feb; 356(7):752; author reply 752-3. PubMed ID: 17301312
    [No Abstract]   [Full Text] [Related]  

  • 4. 21-Gene expression profile assay on core needle biopsies predicts responses to neoadjuvant endocrine therapy in breast cancer patients.
    Akashi-Tanaka S; Shimizu C; Ando M; Shibata T; Katsumata N; Kouno T; Terada K; Shien T; Yoshida M; Hojo T; Kinoshita T; Fujiwara Y; Yoshimura K
    Breast; 2009 Jun; 18(3):171-4. PubMed ID: 19410462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Population-based molecular prognosis of breast cancer by transcriptional profiling.
    Ma Y; Qian Y; Wei L; Abraham J; Shi X; Castranova V; Harner EJ; Flynn DC; Guo L
    Clin Cancer Res; 2007 Apr; 13(7):2014-22. PubMed ID: 17404081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oncotype DX DCIS score predicts recurrence.
    Cancer Discov; 2015 Feb; 5(2):OF3. PubMed ID: 25656901
    [No Abstract]   [Full Text] [Related]  

  • 7. Reducing local recurrence after breast-conserving surgery for breast cancer.
    Liakakos T; Baltogiannis G
    Ann Surg Oncol; 2008 Mar; 15(3):949-50. PubMed ID: 17922227
    [No Abstract]   [Full Text] [Related]  

  • 8. Breast cancer molecular subtypes in patients with locally advanced disease: impact on prognosis, patterns of recurrence, and response to therapy.
    Huber KE; Carey LA; Wazer DE
    Semin Radiat Oncol; 2009 Oct; 19(4):204-10. PubMed ID: 19732684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular predictors of locoregional recurrence in breast cancer: ready for prime time?
    Haffty BG; Buchholz TA
    J Clin Oncol; 2010 Apr; 28(10):1627-9. PubMed ID: 20194835
    [No Abstract]   [Full Text] [Related]  

  • 10. Gene expression profiling of breast cancer to select women for adjuvant chemotherapy.
    Technol Eval Cent Assess Program Exec Summ; 2008 Apr; 22(13):1-8. PubMed ID: 18663816
    [No Abstract]   [Full Text] [Related]  

  • 11. Using microarray analysis as a prognostic and predictive tool in oncology: focus on breast cancer and normal tissue toxicity.
    Nuyten DS; van de Vijver MJ
    Semin Radiat Oncol; 2008 Apr; 18(2):105-14. PubMed ID: 18314065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defining the clinical utility of gene expression assays in breast cancer: the intersection of science and art in clinical decision making.
    Sparano JA; Solin LJ
    J Clin Oncol; 2010 Apr; 28(10):1625-7. PubMed ID: 20065178
    [No Abstract]   [Full Text] [Related]  

  • 13. Innovative approaches to treating metastatic breast cancer.
    Clin Adv Hematol Oncol; 2007 May; 5(5 Suppl 9):4-20; quiz following 20. PubMed ID: 17763634
    [No Abstract]   [Full Text] [Related]  

  • 14. Changing paradigms in breast cancer management: introducing molecular genetics into the treatment algorithm.
    Rayhanabad JA; Difronzo LA; Haigh PI; Romero L
    Am Surg; 2008 Oct; 74(10):887-90. PubMed ID: 18942607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Revised guidelines signal that gene expression profiles are coming of age.
    Benowitz S
    J Natl Cancer Inst; 2008 Jul; 100(13):916-7. PubMed ID: 18577742
    [No Abstract]   [Full Text] [Related]  

  • 16. Factor V Leiden and prothrombin G20210A polymorphisms are not associated with disease-free survival in breast cancer.
    Eroglu A; Cam R; Eğin Y; Akar N
    Breast Cancer Res Treat; 2009 Aug; 116(3):619-20. PubMed ID: 18777205
    [No Abstract]   [Full Text] [Related]  

  • 17. [Identification of the differentially expressed genes between primary breast cancer and paired lymph node metastasis through combining mRNA differential display and gene microarray].
    Feng YM; Gao G; Zhang F; Chen H; Wan YF; Li XQ
    Zhonghua Yi Xue Za Zhi; 2006 Oct; 86(39):2749-55. PubMed ID: 17199993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between standard clinical and pathologic characteristics and the 21-gene recurrence score in breast cancer patients: a population-based study.
    Wolf I; Ben-Baruch N; Shapira-Frommer R; Rizel S; Goldberg H; Yaal-Hahoshen N; Klein B; Geffen DB; Kaufman B
    Cancer; 2008 Feb; 112(4):731-6. PubMed ID: 18076012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical roundtable monograph: a multidisciplinary approach to the use of oncotype DX in clinical practice.
    Gradishar WJ; Hansen NM; Susnik B
    Clin Adv Hematol Oncol; 2009 Apr; 7(4):1-7. PubMed ID: 19536946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Predictive and prognostic markers of breast cancer. Molecular biological analysis of fixed tumor tissue].
    Petry C; Gehrmann M; von Törne C; Weber K; Stropp U; Hennig G
    Pathologe; 2008 Nov; 29 Suppl 2():181-3. PubMed ID: 18843491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.